Skip to main
JBIO
JBIO logo

JBIO Earnings Dates & Reports

JBIO Most Recent Earnings

Report DateNov 14, 2025
Period EndingQ3 2025
Est. EPS-$0.63
Actual EPS-$0.48
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

JBIO Earnings per Share (EPS) History

Signup for full access
Browse free

JBIO Latest Earnings

The value each JBIO share was expected to gain vs. the value each share gained.

JBIO reported its most recent earnings on Nov 14, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.48. This exceeded analysts' expectations of -$0.63 by 23.81%, marking a Beat.

For comparison, Aerovate Therapeutics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 02/05/2026, with analysts projecting an EPS of -$0.47.

JBIO Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Mar 25, 2026
-$0.47Next earnings call Feb. 5, 2026
Q3 2025Nov 14, 2025
-$0.63-$0.48-23.81%
DeckReportListen
Q2 2025Aug 13, 2025
-$0.43-$0.86+100.00%
DeckReportListen

JBIO Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Aerovate Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 13, 2025
Aug 13, 2025

JBIO Earnings FAQs

JBIO last reported earnings on Nov 14, 2025 for Q3 2025, posting an EPS of -$0.48, which Beat the estimate of -$0.63 by 23.81%.

For Q3 2025, JBIO reported an EPS of -$0.48, exceeding analysts' estimate of -$0.63 by 23.81%.

For Q3 2025, JBIO Beat expectations with an actual EPS of -$0.48 vs. an estimated EPS of -$0.63.

Following the last earnings report on Nov 14, 2025, JBIO's stock price moved — from — to —.

The next JBIO earnings call is scheduled for Feb. 5, 2026, where executives will discuss financial results and outlook.

Aerovate Therapeutics Inc (JBIO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.